{"nctId":"NCT04679818","briefTitle":"Postoperative Consequences of Intraoperative NOL Titration","startDateStruct":{"date":"2020-12-30","type":"ACTUAL"},"conditions":["Anesthesia; Adverse Effect"],"count":72,"armGroups":[{"label":"PMD-200 NOL group","type":"ACTIVE_COMPARATOR","interventionNames":["Device: PMD-200 Nol-guided opioid administration"]},{"label":"Control Group","type":"ACTIVE_COMPARATOR","interventionNames":["Drug: Routine opioid management"]}],"interventions":[{"name":"Routine opioid management","otherNames":["Fentanyl"]},{"name":"PMD-200 Nol-guided opioid administration","otherNames":["PMD-200 NOL"]}],"eligibilityModule":{"eligibilityCriteria":"Inclusion Criteria:\n\n* Adults having major non-cardiac surgery expected to last ≥2 hours\n* American Society of Anesthesiologists physical status 1-3\n* Age 21-85 years old\n* Planned endotracheal intubation\n\nExclusion Criteria:\n\n* Planned neuraxial or regional block\n* Clinician preference for an opioid other than, or in addition to, fentanyl\n* Non-sinus heart\n* Neurologic condition that, in the opinion of the investigators, may preclude accurate assessment of postoperative pain and nausea\n* Lack of English language fluency\n* Routine user of psychoactive drugs other than opioids\n* Contraindication to sevoflurane, fentanyl, morphine, or ondansetron.\n* Intracranial surgery.\n* BMI \\> 40","healthyVolunteers":false,"sex":"ALL","minimumAge":"21 Years","maximumAge":"85 Years","stdAges":["ADULT","OLDER_ADULT"]},"locations":{"multicenter":false},"periods":[],"outcomeMeasures":[{"type":"PRIMARY","title":"Pain Scores at 10-minute Intervals for the Initial Hour of Recovery","description":"Pain scores are measured using a Verbal Response Scale (VRS) every 10 minutes in the initial hour of recovery. VRS is a scale from 0 to 10 where 0 signifies no pain and 10 signifies the worst pain ever experienced.","paramType":"MEDIAN","dispersionType":"Inter-Quartile Range","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"0","spread":null},{"groupId":"OG001","value":"0","spread":null}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"1.0","spread":null},{"groupId":"OG001","value":"5.0","spread":null}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"2.5","spread":null},{"groupId":"OG001","value":"5.0","spread":null}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"5.0","spread":null},{"groupId":"OG001","value":"4.0","spread":null}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"4.5","spread":null},{"groupId":"OG001","value":"3.0","spread":null}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"4.5","spread":null},{"groupId":"OG001","value":"3.0","spread":null}]}]}]},{"type":"PRIMARY","title":"Pain Scores at 10-minute Intervals for the Initial 30 Minutes of Recovery","description":"Pain scores are measured using a Verbal Response Scale (VRS) at 10-minute intervals for the initial 30 minutes of recovery. VRS is a scale from 0 to 10 where 0 signifies no pain and 10 signifies the worst pain ever experienced.","paramType":"MEAN","dispersionType":"Inter-Quartile Range","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"0","spread":null},{"groupId":"OG001","value":"0","spread":null}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"1.0","spread":null},{"groupId":"OG001","value":"5.0","spread":null}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"2.5","spread":null},{"groupId":"OG001","value":"5.0","spread":null}]}]}]},{"type":"SECONDARY","title":"Number of Measurements With Pain Score Less Than 5 (vs ≥5) for Initial Hour of Recovery","description":"Binary repeated-measures outcome of pain score will be defined as a pain score less than 5 (vs ≥5). Pain scores will be measured using a Verbal Response Scale (VRS) at 10-minute intervals for the initial hour of recovery. VRS is a scale from 0 to 10 where 0 signifies no pain and 10 signifies the worst pain ever experienced.","paramType":"NUMBER","dispersionType":null,"classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"112","spread":null},{"groupId":"OG001","value":"130","spread":null}]}]}]},{"type":"SECONDARY","title":"Number of Measurements With Pain Score Less Than 5 (vs ≥5) for the Initial 30 Minutes of Recovery","description":"Binary repeated-measures outcome will be defined as a pain score less than 5 (vs ≥5). Pain scores will be measured using a Verbal Response Scale (VRS) at 10-minute intervals for the 30 minutes of recovery. VRS is a scale from 0 to 10 where 0 signifies no pain and 10 signifies the worst pain ever experienced.","paramType":"NUMBER","dispersionType":null,"classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"63","spread":null},{"groupId":"OG001","value":"61","spread":null}]}]}]},{"type":"OTHER_PRE_SPECIFIED","title":"Number of Analgesic Rescue Boluses","description":"Number of analgesic rescue boluses in the first 60 minutes after extubation.","paramType":"MEDIAN","dispersionType":"Inter-Quartile Range","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"1","spread":null},{"groupId":"OG001","value":"2","spread":null}]}]}]},{"type":"OTHER_PRE_SPECIFIED","title":"Ramsay Scores During the First 60 Minutes","description":"Ramsay scores will be measured using Ramsay Sedation Scale every 10 minutes in the initial hour of recovery. Ramsay Sedation Scale: 1 = Patient is anxious and agitated or restless, or both; 2 = Patient is co-operative, oriented, and tranquil; 3 = Patient responds to commands only; 4 = Patient exhibits brisk response to light glabellar tap or loud auditory stimulus; 5 = Patient exhibits a sluggish response to light glabellar tap or loud auditory stimulus; 6 = Patient exhibits no response. Frequencies for each score were reported.","paramType":"NUMBER","dispersionType":null,"classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"0","spread":null},{"groupId":"OG001","value":"1","spread":null}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"92","spread":null},{"groupId":"OG001","value":"85","spread":null}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"106","spread":null},{"groupId":"OG001","value":"132","spread":null}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"5","spread":null},{"groupId":"OG001","value":"3","spread":null}]}]}]},{"type":"OTHER_PRE_SPECIFIED","title":"Treatment Effect on the Time to Emergence From Anesthesia.","description":"Time to emergence from anesthesia is defined as minutes from discontinuation of sevoflurane anesthesia to extubation","paramType":"MEDIAN","dispersionType":"Inter-Quartile Range","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"18","spread":null},{"groupId":"OG001","value":"20","spread":null}]}]}]}],"adverseEventsModule":{"adverseEventsSummary":{"seriousAny":{"events":0,"n":35},"commonTop":[]}}}